Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing’ vascular segments

1 week ago 6
ARTICLE AD BOX
Penumbra’s stock was up about 14% after the deal was announced Thursday morning.
Read Entire Article
  1. Homepage
  2. Finance
  3. Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing’ vascular segments

Related

General Motors takes $7.2 billion charge on EV shift as it boosts dividend and sets new buyback

General Motors takes $7.2 billion charge on EV shift as it b...

16 minutes ago 0
Boeing beats revenue expectations by a wide margin, as airplane deliveries nearly triple

Boeing beats revenue expectations by a wide margin, as airpl...

36 minutes ago 0
This chart tracks the ‘single greatest predictor’ of stock-market returns — and it’s never done this before

This chart tracks the ‘single greatest predictor’ of stock-m...

50 minutes ago 0

Trending

Popular

Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

10 months ago 499
‘I didn’t want to spend time with my children. I was just going through the motions’: the pain of parental burnout

‘I didn’t want to spend time with my children. I was just go...

11 months ago 458
‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided Beauty Standards Through Asian Eyes

‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided...

10 months ago 436
Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

11 months ago 392
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

11 months ago 346
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2026. All rights are reserved